Targeted Warming Capsaicin Patch .025 g/100g Patch — NDC 55301-904-01 (Billing 55301-0904-01)
This is a package of Targeted Warming Capsaicin Patch .025 g/100g Patch from Army & Air Force Exchange Service, marketed since Jul 2026 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 55301-904-01 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 55301 labeler · 904 product · 01 package
- Package marketed since
- Jul 1, 2026
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC)
- 0614299594142
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 1043399
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Capsaicin and similar agents class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
- Yes, completely normal — and it actually means the medicine is working. Capsaicin activates the same pain-sensing receptors in your skin that respond to heat and spicy food. That b...
- Why does capsaicin burn when I put it on? Is that normal?
- For most OTC creams and ointments, you can apply up to 3 to 4 times a day. For OTC patches, apply to clean, dry skin and remove after no more than 8 hours — again, up to 3 to 4 tim...
- How often should I apply capsaicin cream or use the patch?
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Capsaicin (prescription drug) — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 6, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 55301-0904-01 You're viewing this Main listing | 3 PATCH in 1 POUCH / 4 g in 1 PATCH | 2026-07-01 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Good Neighbor Capsaicin Heat Patch for Back .025 g/100g 46122-0753-55 | Amerisource | 3 patches | $1.117 | — | Availability likely | — |
| Capsaicin Hot Patches .025 g/100g 70000-0556-01 | Cardinal | 2 patches | $1.117 | — | Availability likely | — |
| Capsaicin .025 g/100g 50488-2025-01 | Alexso, | 10 patches | — | — | FDA listed | — |
| Capsaicin Heat Patches Back And Large Areas .025 g/100g 00363-9902-03 | Walgreen | 3 patches | — | — | FDA listed | — |
| Capsaicin .025 g/100g 69420-7025-01 | SA3, | 10 patches | — | — | FDA listed | — |
| Honest Med Capsaicin Patch .025 g/100g 84097-0003-24 | Proper | 24 patches | — | — | FDA listed | — |
| Solstice Capsaicin Patch Hot .025 g/100g 55614-0410-01 | MADISON | 1 patch | — | — | FDA listed | — |
| Capsaicin Heat Patches Back And Large Areas .025 g/100g 41250-0842-03 | Meijer | 3 patches | — | — | FDA listed | — |
| Capsaicin Heat .025 g/100g 52000-0040-41 | Universal | 2 patches | — | — | FDA listed | — |
| Capsaicin .025 g/100g 79643-0002-01 | PHARMACURE | 10 patches | — | — | FDA listed | — |
| Capsaicin Heat Patches Pain Relief .025 g/100g 11822-4210-03 | Rite | 3 patches | — | — | FDA listed | — |
| HealthWise Capsaicin Heat Patch .025 g/100g 71101-0030-20 | Veridian | 20 patches | — | — | FDA listed | — |
| Capsaicin .025 g/100g 71436-3025-01 | ARI | 10 patches | — | — | FDA listed | — |
| Meijer Capsaicin Heat Patch .025 g/100g 79481-0064-03 | Meijer | 3 patches | — | — | FDA listed | — |
| Targeted Warming Capsaicin Patch .025 g/100gthis 55301-0904-01 | Army | 3 patches | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Capsaicin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 39EYQ1W9RB
A synthetic oil made from hydrogenated plant or petroleum waxes. It serves as a lubricant and glidant in tablet or capsule formulations to reduce friction during manufacturing and improve powder flow.
-
UNII 6ZAE7X688J
A refined mineral oil derived from crude petroleum. It serves as a lubricant and binder in tablet and capsule formulations, helping medicines slide smoothly through manufacturing equipment and improving how ingredients stick together.
-
UNII 255PIF62MS
A synthetic antioxidant compound used to prevent oils and fats in medications from breaking down or becoming rancid during storage. It helps maintain the medicine's stability and shelf life.
-
UNII H58HX2GWJ5
A synthetic rubber made from styrene and isoprene monomers. It serves as a film-former and binder in tablet coatings and sustained-release formulations to control how quickly the medicine dissolves and releases.
4 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 6, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Army & Air Force Exchange Service labeler code 55301
- Antifungal Powder Tolnaftate 10 mg/g Aerosol, Spray NDC 55301-874-01
- Salicylic Acid Astringent 5 mg/mL Liquid NDC 55301-875-34
- Ethyl Rubbing Alcohol 70 mL/100mL Liquid NDC 55301-876-43
- Docosanol 100 mg/g Cream NDC 55301-877-07
- Exchange Select Esomeprazole Magnesium 20 mg Capsule, Delayed Release NDC 55301-898-01
- Suphedrine PE Sinus Pressure Plus Pain Acetaminophen, Phenylephrine HCl 325 mg; 5 mg Tablet NDC 55301-902-08
- MAXIMUM STRENGTH Lidocaine Plus Menthol 4 g/100g; 1 g/100g Patch NDC 55301-912-05
- exchange select omeprazole 20 mg Tablet, Delayed Release NDC 55301-915-55
- Oil Free Acne Wash Salicylic Acid 2% 20 mg/mL Lotion NDC 55301-947-06
- exchange select nicotine Nicotine Polacrilex 4 mg Lozenge NDC 55301-957-60
- Sleep Aid Doxylamine Succinate 25 mg Tablet NDC 55301-986-27
- Exchange Select Maximum Redness Relief Eye Drops Glycerin, Naphazoline HCl .5 g/100mL; .03 g/100mL Solution/ Drops NDC 55301-998-01
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses Temporary relief of minor pain of muscles and joints associated with: arthritis, minor backache, strains, sprains and bruises
⏱️ Dosage and Administration ▾
Directions adults and children 12 years of age and over: Clean and dry affected area, free of lotions, ointments and creams. Carefully remove backing starting at a corner. Apply sticky side of patch to affected area. Do not use more than one patch in an 8 hour period. Repeat as necessary. Maximum 3 patches per day. Discard patch after single use. children under 12 years of age: consult a physician
⚠️ Warnings ▾
Warnings For external use only
Allergy alert If you are allergic or suspect you are allergic to the ingredients of this product, including chili peppers, consult with your physician before use.
🧪 Active Ingredient ▾
Active ingredient Capsaicin 0.025%
🧪 Inactive Ingredients ▾
Inactive ingredients hydrogenated C6-20 polyolefin, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, petroleum, styrene/isoprene copolymer
🎯 Purpose ▾
Purpose External analgesic
📄 Do Not Use ▾
Do not use on wounds or damaged skin with pain rubs, medicated lotions, creams or ointments with a heating pad
📄 When Using This Product ▾
When using this product use only as directed avoid contact with eyes, mucous membranes or rashes do not bandage tightly discontinue use at least 1 hour before a bath or shower do not use immediately after a bath or shower do not microwave dispose of used patch in manner that always keeps product away from children and pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch.
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if skin reactions such as redness, itching, rash, excessive irritation, burning sensation, swelling or blistering occur condition worsens symptoms persist more than 7 days symptoms clear and reoccur within a few days
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast-feeding If pregnant or breast-feeding, ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children If swallowed, contact a poison control center (1-800-222-1222) right away.
📄 Other Information ▾
Other information Avoid storage in direct sunlight Protect patch from excessive moisture
📄 Questions or Comments ▾
Questions or comments? call 1-866-326-1313
📄 Package Label / Principal Display Panel ▾
Principal Display Panel label
Reported adverse events (FAERS)
Top reported reactions
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |